These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 7254231)

  • 41. Human IgG monoclonal autoantibodies against muscle acetylcholine receptor: direct evidence for clonal heterogeneity of the antiself humoral response in myasthenia gravis.
    Cardona A; Garchon HJ; Vernet-der-Garabedian B; Morel E; Gajdos P; Bach JF
    J Neuroimmunol; 1994 Aug; 53(1):9-16. PubMed ID: 8051300
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical comparison of anti-MuSK- vs anti-AChR-positive and seronegative myasthenia gravis.
    Deymeer F; Gungor-Tuncer O; Yilmaz V; Parman Y; Serdaroglu P; Ozdemir C; Vincent A; Saruhan-Direskeneli G
    Neurology; 2007 Feb; 68(8):609-11. PubMed ID: 17310034
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Treatment of myasthenia gravis by preventing acetylcholine receptor modulation.
    Losen M; Martínez-Martínez P; Phernambucq M; Schuurman J; Parren PW; De Baets MH
    Ann N Y Acad Sci; 2008; 1132():174-9. PubMed ID: 18567867
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Myasthenia gravis experimentally induced with muscle-specific kinase.
    Shigemoto K; Kubo S; Jie C; Hato N; Abe Y; Ueda N; Kobayashi N; Kameda K; Mominoki K; Miyazawa A; Ishigami A; Matsuda S; Maruyama N
    Ann N Y Acad Sci; 2008; 1132():93-8. PubMed ID: 18096854
    [TBL] [Abstract][Full Text] [Related]  

  • 45. IgG from "seronegative" myasthenia gravis patients binds to a muscle cell line, TE671, but not to human acetylcholine receptor.
    Blaes F; Beeson D; Plested P; Lang B; Vincent A
    Ann Neurol; 2000 Apr; 47(4):504-10. PubMed ID: 10762162
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Anesthetic considerations for thymectomy in a patient having an anti-acetylcholine receptor antibody without myasthenia gravis].
    Koshida T; Hara K; Obara G; Sata T
    Masui; 2008 Aug; 57(8):993-5. PubMed ID: 18710007
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Complement activation in myasthenia gravis plasma by Torpedo acetylcholine receptor liposomes.
    DuPont BL; Koethe SM; McQuillen MP
    Immunol Invest; 1985 Oct; 14(5):415-20. PubMed ID: 4077155
    [TBL] [Abstract][Full Text] [Related]  

  • 48. D-Penicillamine-associated myasthenia gravis: immunological and electrophysiological studies.
    Fawcett PR; McLachlan SM; Nicholson LV; Argov Z; Mastaglia FL
    Muscle Nerve; 1982 Apr; 5(4):328-34. PubMed ID: 7099199
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Idiotypes and anti-idiotypes of human autoantibodies to the acetylcholine receptor in myasthenia gravis.
    Lefvert AK
    Monogr Allergy; 1987; 22():57-70. PubMed ID: 3325836
    [No Abstract]   [Full Text] [Related]  

  • 50. Towards antigen-specific apheresis of pathogenic autoantibodies as a further step in the treatment of myasthenia gravis by plasmapheresis.
    Zisimopoulou P; Lagoumintzis G; Kostelidou K; Bitzopoulou K; Kordas G; Trakas N; Poulas K; Tzartos SJ
    J Neuroimmunol; 2008 Sep; 201-202():95-103. PubMed ID: 18667243
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evidence against acetylcholine receptor having a main immunogenic region as target for autoantibodies in myasthenia gravis.
    Lennon VA; Griesmann GE
    Neurology; 1989 Aug; 39(8):1069-76. PubMed ID: 2474772
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies.
    Hoch W; McConville J; Helms S; Newsom-Davis J; Melms A; Vincent A
    Nat Med; 2001 Mar; 7(3):365-8. PubMed ID: 11231638
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The effects of T cell subpopulations and recombinant interleukin (IL)-2 on peripheral B cell function in patients with myasthenia gravis.
    Zhang J; Zhou WB; Wang HL; Guo SS
    Hum Antibodies; 1997; 8(2):90-4. PubMed ID: 9289393
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Production of anti-acetylcholine receptor-alpha antibody in vitro by peripheral blood lymphocytes of patients with myasthenia gravis: role of immunoregulatory T cells and monocytes.
    Ofosu-Appiah W; Mokhtarian F; Shirazian D; Grob D
    J Lab Clin Med; 1994 Aug; 124(2):231-41. PubMed ID: 8051487
    [TBL] [Abstract][Full Text] [Related]  

  • 55. New antigen for antibody detection in myasthenia gravis.
    Gotti C; Mantegazza R; Clementi F
    Neurology; 1984 Mar; 34(3):374-7. PubMed ID: 6538281
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Neonatal myasthenia gravis in the infant of a myasthenic mother in remission.
    Elias SB; Butler I; Appel SH
    Ann Neurol; 1979 Jul; 6(1):72-5. PubMed ID: 574370
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Structure of receptors and expression of anti-receptor antibodies. b. Anti-acetylcholine receptor antibodies].
    Takamori M; Okumura S; Nagata M
    Nihon Rinsho; 1988 Apr; 46(4):816-21. PubMed ID: 3261359
    [No Abstract]   [Full Text] [Related]  

  • 58. Clonotypic analysis of anti-acetylcholine receptor antibodies produced against native and denatured antigen.
    Yeh TM; Krolick KA
    J Neuroimmunol; 1989 Sep; 24(1-2):133-42. PubMed ID: 2478576
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Molecular mimicry and myasthenia gravis. An autoantigenic site of the acetylcholine receptor alpha-subunit that has biologic activity and reacts immunochemically with herpes simplex virus.
    Schwimmbeck PL; Dyrberg T; Drachman DB; Oldstone MB
    J Clin Invest; 1989 Oct; 84(4):1174-80. PubMed ID: 2551924
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Measurement of anti-acetylcholine receptor auto-antibodies in myasthenia gravis.
    Steenkamp KJ; Duim W; Myer MS; Malfeld SC; Anderson R
    S Afr Med J; 1995 Dec; 85(12):1293-4. PubMed ID: 8600588
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.